These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3523543)

  • 1. Biological half-life of prostacyclin and 6-oxo-PGF1 alpha levels in plasma of patients with colonic cancer.
    Polterauer P; Sinzinger H; Peskar BA
    Prostaglandins Leukot Med; 1986 Jun; 22(3):249-58. PubMed ID: 3523543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma-6-oxo-PGF1-alpha but normal PGI2 half-life in patients with maxillo-facial tumors.
    Porteder H; Matejka M; Kment G; Nell A; Sinzinger H
    Prog Clin Biol Res; 1987; 242():123-9. PubMed ID: 3313409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of irradiation on the biological half-life of prostacyclin in plasma of patients with gastrointestinal cancer.
    Polterauer P; Sinzinger H; Peskar BA
    Br J Exp Pathol; 1987 Oct; 68(5):637-42. PubMed ID: 3318903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostacyclin in the circulation of patients with vascular disorders undergoing surgery.
    Ritter JM; Hamilton G; Barrow SE; Heavey DJ; Hickling NE; Taylor KM; Hobbs KE; Dollery CT
    Clin Sci (Lond); 1986 Dec; 71(6):743-7. PubMed ID: 3539459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostanoid synthesis by aortic rings in human blood: selective increase of prostacyclin mediated by a serum factor.
    Ritter JM
    Br J Pharmacol; 1984 Oct; 83(2):409-18. PubMed ID: 6386089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion.
    Ylikorkala D; Viinikka L
    Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry.
    Hensby CN; Fitzgerald GA; Friedman LA; Lewis PJ; Dollery CT
    Prostaglandins; 1979 Nov; 18(5):731-6. PubMed ID: 396578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostacyclin and thromboxane A2 in thrombotic thrombocytopenic purpura.
    Lee SH; Wainscoat JS; Zeitlin H; Bolton FG; Leaver HA; Seawright A; Preece JM
    Br Med J (Clin Res Ed); 1981 Nov; 283(6303):1351-2. PubMed ID: 6797537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of prostacyclin (PGI2) and 6-oxo-PGF1 alpha in anaesthetized dogs.
    Salmon JA; Mullane KM; Dusting GJ; Moncada S; Vane JR
    J Pharm Pharmacol; 1979 Aug; 31(8):529-32. PubMed ID: 39993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma.
    Siess W; Dray F
    J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of vascular prostacyclin (PGI2) production by human serum.
    Ritter JM; Orchard MA; Lewis PJ
    Biochem Pharmacol; 1982 Oct; 31(19):3047-50. PubMed ID: 6756409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of prostacyclin from whole blood.
    Skrinska V; Lucas FV
    Prostaglandins; 1981 Sep; 22(3):365-75. PubMed ID: 7029655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma immunoreactive 6-keto-prostaglandin F1 alpha levels in newborns with idiopathic respiratory distress syndrome.
    Kääpä P; Koivisto M; Viinikka L; Ylikorkala O
    Pediatr Res; 1982 Oct; 16(10):827-9. PubMed ID: 6897290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of prostacyclin in vivo and its role in man.
    Ritter JM; Barrow SE; Blair IA; Dollery CT
    Lancet; 1983 Feb; 1(8320):317-9. PubMed ID: 6130331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of human venous plasma prostacyclin and metabolites by radioimmunoassay: a reappraisal.
    Forder RA; Carey F
    Prostaglandins Leukot Med; 1983 Nov; 12(3):323-46. PubMed ID: 6361783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of platelet-vessel wall prostaglandin equilibrium during exercise-induced stress.
    Mehta J; Mehta P; Horalek C
    Am Heart J; 1983 Jun; 105(6):895-900. PubMed ID: 6344604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasoactive peptides on prostacyclin synthesis in man.
    Barrow SE; Dollery CT; Heavey DJ; Hickling NE; Ritter JM; Vial J
    Br J Pharmacol; 1986 Jan; 87(1):243-7. PubMed ID: 3513880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma levels of 6-oxo-prostaglandin F1 alpha, a stable metabolite of prostacyclin, in acute kidney transplant rejection.
    Leithner C; Sinzinger H; Peskar BA
    Prostaglandins Med; 1981 Jul; 7(1):15-8. PubMed ID: 7025069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat.
    Falardeau P; Robillard M; Martineau A
    Prostaglandins; 1985 Apr; 29(4):621-8. PubMed ID: 3890022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transepithelial prostacyclin gradient in isolated canine trachea.
    Eidelman DH; Powell WS; Bellofiore S; Martin JG
    J Appl Physiol (1985); 1989 Jul; 67(1):276-81. PubMed ID: 2668255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.